Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job


Position:
Scientist I - Translational Omics

Employer:
PTC Therapeutics

Description:

The Scientist I, Translation Omics will use cutting edge analytical techniques, with a focus on mass spectrometry, to identify new biological targets, verify compound engagement and ascertain pharmacodynamic effects across the PTC Therapeutics pipeline. The candidate will join a diverse team employing multi-omics approaches to interrogate both cellular metabolism/flux as well as systems level biological changes associated with genetic and/or disease phenotypes.

Primary duties and responsibilities will include: 

  • Create and optimize quantitative LC-MS based targeted assays (SRM/MRM) across a diverse range of biomarker classes.
  • Develop new and improve upon existing sample preparation procedures for LC-MS assays conducive to multi-omics analyses of cellular systems, biofluids, and tissues.
  • Expand existing biomarker assays to greater cover targeted disease pathways.
  • Integrate and visualize multi-omic datasets to elucidate changes in dynamic biological systems.

The Scientist I, Translation Omics is responsible for planning and performing scientific experiments that contribute to PTC’s research and drug discovery activities. The incumbent works cross-functionally with internal departments, and external resources as appropriate, as part of PTC’s discovery science project teams.

The Scientist I, Translational Omics supports adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs) as appropriate.



Qualifications/Experience:
  • Extensive hands-on experience with both targeted (QQQ) and high resolution (FTICR, Q-ToF, etc.) mass spectrometers
  • Detailed knowledge of separation techniques for small and large molecules with applied experience on chromatography systems in multiple flow regimes (e.g. micro and nano)
  • Experience with developing isolation, enrichment, and purification strategies for both rare and less stable analytes in multiple biological matrices
  • Capable of working with large datasets, proficient in data processing/reduction strategies, and experience with both statistical and visualization software packages
  • Prior use of isotopically labeled workflows (e.g. SILAC, iTRAQ, etc.) to measure cellular flux and/or quantitate multi-omics changes without a priori knowledge is preferred
  • While multi-omics experience is preferred, exceptional candidates focusing on a single omics field (e.g. metabolomics, spatial-omics,  lipidomics, phosphoproteomics, etc.) will be considered


Location: Mountain View, CA

Contact: jlatham@ptcbio.com

Post Date: 4/28/2021 12:56:47 PM
©Pharmaceutical & BioScience Society, International; Last Modified: 4/19/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad